Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

GE HealthCare is a new Buy at Oppenheimer, analysts see 30% upside

Published 16/05/2023, 11:20 pm
Updated 16/05/2023, 11:20 pm
© Reuters.

© Reuters.

Oppenheimer analysts initiated research coverage of GE HealthCare (NASDAQ:GEHC) with a Buy rating and a $97 per share price target.

The target implies an upside potential of about 30% relative to yesterday’s closing price.

GE HealthCare, which was spun off by General Electric (NYSE:GE) earlier this year, is described as “the global leader in healthcare diagnostics, imaging, and intervention.”

“GE's unparalleled depth and breadth of products in X-rays, CT, MRI, ultrasound, services, and digital solutions provide a unique ecosystem allowing multiple touch points along the continuum of care. Following its recent spin-out from the parent company, a more focused GE has emerged with a strategic outlook of a 4-6% revenue CAGR, adjusted EBIT margins of high-teens to twenty percent, and FCF generation of 85%+,” analysts said in a client note.

Hence, analysts are positive on GEHC shares as the company operates in attractive markets while being financially disciplined.

GEHC shares are up 0.5% in pre-market Tuesday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.